Kinetics of human butyrylcholinesterase inhibition by 1,9-dimethyl-methylene blue

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Journal of the Turkish Chemical Society Section A: Chemistry
Volume:8 Issue:2
Kinetics of human butyrylcholinesterase inhibition by 1,9-dimethyl-methylene blue

Kinetics of human butyrylcholinesterase inhibition by 1,9-dimethyl-methylene blue

Pages : 435-442

View : 47 | Download : 14

Publication Date : 2021-05-31

Article Type : Research Paper

Abstract :Alzheimer’s disease insert ignore into journalissuearticles values(AD); is an irreversible and progressive neurodegenerative disorder, characterized by β-amyloid plaques, neurofibrillary tangles and loss of cholinergic neurons. Butyrylcholinesterase insert ignore into journalissuearticles values(BChE); inhibition is one of the most critical strategy for the treatment of AD since BChE causes inactivation of neurotransmitter acetylcholine and has positive effects on promoting the formation of β-amyloid fibrils. Our previous studies showed that various phenothiazine-derived compounds such as thionine and toluidine blue O insert ignore into journalissuearticles values(TBO); cause a potent inhibition of human cholinesterases. TBO was also found to reduce amyloid precursor protein processing in-vitro and in-vivo models of AD. In this study, it was aimed to determine the inhibitory effect of 1,9-dimethyl-methylene blue insert ignore into journalissuearticles values(DMMB);, a phenothiazine-derived compound, on human plasma BChE and explore its inhibitory mechanism. The inhibition of human BChE was assessed by the colorimetric method of Ellman using butyrylthiocholine as substrate and 0-0.375 μM of DMMB. The kinetic findings showed that DMMB acts as a linear mixed-type inhibitor of human BChE with Ki value of 23 ± 0.004 nM and α= 3.6 ± 1.6. It was concluded that DMMB, which is a potent inhibitor effective at nM level may be helpful in designing new cholinesterase inhibitors for the treatment of AD.
Keywords : Alzheimers disease, butyrylcholinesterase, 1, 9 dimethyl methylene blue, cholinesterase inhibition, phenothiazine

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.